Annovis Bio press release (ANVS): Q2 GAAP EPS of -$0.40 beats by $0.05. Annovis’ cash and cash equivalents totaled $18.7 million as of June 30, 2026
$ANVS
Price history, market instrument context, member research, and related headlines in one place.
ANVS key statistics
NYSEUSD
52-week range
$1.010%$5.50
Latest session $1.01–$1.08Annovis Bio, Inc. (ANVS) is a stock instrument quoted on NYSE in USD. The most recently published price is $1.02, down $0.04 (3.77%) from the previous close of $1.06. It has traded between $1.01 and $1.08 in the latest session. Over the past year it has ranged from $1.01 to $5.50, leaving it trading near the bottom of its 52-week range. Reported volume for the session was 843.7K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Loading $ANVS research…